retatrutide gallbladder Mazdutide vs retatrutide: dual agonist meets triple agonist in the next-gen weight loss showdown Retatrutide 30mg Triple-Receptor Metabolic Research

Promising results have also been seen in obesity-related fatty liver with fibrosis

Research aims to determine whether GLP-3 causes similar GI side effects as GLP-1, if tolerability differs between the peptides, what optimal dosing strategies minimize side effects, and if GLP-3 might suit patients who dont tolerate GLP-1 agonists well

GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival

Erik Marks, DNP, designs customized programs that focus on body composition, hormone balance, and metabolic optimization

Visuals That Caught Our Eye, at the end, spotlights compelling charts and graphs that stood out this week